Rehabilitation Center of the University Children's Hospital
Affoltern am Albis, Canton of Zurich, 8910, Switzerland
NCT Number: NCT03787199
The overall aim of this project is to investigate the clinical utility of the Andago System, a CE certified mobile bodyweight supporting walking robot, in children with neuromotor disorders. Clinical utility encompasses practicability, acceptability, appropriateness, and accessibility. In this study, the investigators would like to investigate several aspects of clinical utility that belong to the first three components.
Looking for future studies?
Notify MeUp to 18 year
All sexes
Interventional
Not applicable
Affoltern am Albis, Canton of Zurich, 8910, Switzerland
The specific aims of the current project are:
To investigate these aims, the patients will be asked to participate in 3 appointments, which should be scheduled within 10 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Andago is a body-weight supporting device with which a patient can walk overground
Bodyweight supported treadmill walking
Time frame: Appointment 3 (between minute 25 and minute 55 )
Variability in stride length recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support
Time frame: Appointment 3 (between minute 25 and minute 55 )
Amplitude of electromyographic recordings recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support
Time frame: Appointment 3 (between minute 25 and minute 55)
Joint angles recorded with electrogoniometers during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support
Time frame: Data are obtained during Appointment 2 (between minute 1 and minute 10)
Comparison of bodyweight unloading according to Andago device compared to actual bodyweight unloading measured with scales [kg]
Time frame: Data are obtained during Appointment 1 between minute 25 and minute 45 and Appointment 2 between minute 10 to 30
Number of Andago device stops measured throughout the habituation periods during appointments 1 and 2
Time frame: At the end of Appointments 1 (between minute 55-58) and the end of Appointment 2 (between minute 40-43)
Participant is being asked whether the patient prefers treadmill or Andago (dichotomous outcome: 0=treadmill/1=Andago), and if the patient would like to train again in the Andago (0=no/1=yes). No sum score is calculated.
Time frame: At the end of Appointments 1 (between minute 59-60) and the end of Appointment 2 (between minute 44-45)
How much fun was it training in the Andago? [score 0=no fun at all to 10=maximal amount of fun]
Time frame: During Appointment 1 (mounting around minute 25; taking off around minute 43) and Appointment 2 (mounting around minute 1; taking off around minute 28)
Time in seconds needed for mounting the patient in the Andago and, at the end of walking in the Andago, the time needed to get the patient out of the device
Time frame: Appointment 1 between minute 1 and 5
Manual muscle testing is performed for providing a characterization of the patients. For each muscle group, a score is given between 0 (no visible or palpable contraction) and 5 (patient moves over the full range of motion against gravity with additional maximal resistance). The following muscles will be tested: hip flexors and extensors; hip inner- and outer-rotators; knee flexors and extensors; ankle plantar and dorsal flexors
Time frame: Appointment 1 between minute 6 and 15 minutes
The SCALE assesses the selectivity of lower extremity joints. It provides a score between 0 (not able) and 2 (normal selectivity) for each of the following joints: hip, knee, ankle, subtalar joint, and toes. It provides a sum score for the left and right leg separately (0= not able; 10= normal selectivity) and an overall sum score (0=not able; 20=normal selectivity)
Time frame: Appointment 1 between minute 16 and 20 minutes
Active (by patient) and passive (by therapist) mobility of the hip, knee and ankle joints are made in the sagittal plane. The ROM is noted according to the neutral zero method (degrees). ROM testing is performed for providing a characterization of the patients.
Time frame: Appointments 1 between minute 21 and 25 and Appointment 3 between minute 1 and 5 and 56 and 60
Children walk 14 meters; intermediate 10 meters is time stopped to calculate the walking speed
University Children's Hospital, Zurich
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05759182
Brain Damage, Chronic, Brain Diseases
Seongdong, Seoul, South Korea
View Trial DetailsNCT05229523
Brain Damage, Chronic, Brain Diseases
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT05957783
Brain Damage, Chronic, Brain Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06497309
Brain Diseases, Cardiovascular Diseases
Budapest, Pest County, Hungary
View Trial Details